Methylglyoxal and glycolaldehyde (MG and GA)

Methylglyoxal and glycolaldehyde are highly reactive carbonyl species (RCS) that serve as potent precursors to advanced glycation end-products (AGEs) [Thornalley, 2003]. Methylglyoxal is primarily generated as a byproduct of glycolysis through the non-enzymatic degradation of triose phosphates, while glycolaldehyde is often produced via the myeloperoxidase system during inflammation or through serine metabolism [Brownlee, 2001]. These molecules are characterized by their ability to rapidly react with the amino groups of proteins, lipids, and nucleic acids, leading to the formation of irreversible cross-links and structural damage [Khalifah et al., 1999]. This process, known as "carbonyl stress," is a significant driver of diabetic complications, including nephropathy and retinopathy, as well as neurodegenerative conditions like Alzheimer's disease [Brownlee, 2001]. Therapeutic strategies targeting these molecules focus on "carbonyl scavenging," where small molecules like aminoguanidine or pyridoxamine chemically neutralize the dicarbonyls before they can modify host proteins [Khalifah et al., 1999]. Despite their clinical relevance, targeting these metabolites is challenging due to their rapid turnover and the potential for scavengers to interfere with essential metabolic pathways or vitamin B6 homeostasis [Cassiman et al., 1997].

Other names

Reactive dicarbonylsReactive carbonyl species (RCS)Advanced glycation end-product (AGE) precursors2-oxopropanal2-hydroxyacetaldehyde

Chemical scavenging of reactive carbonyl groups and inhibition of advanced glycation end-product (AGE) formation.